Pages that link to "Q36589249"
Jump to navigation
Jump to search
The following pages link to Treatment of schizophrenia and comorbid substance abuse: pharmacologic approaches (Q36589249):
Displaying 8 items.
- Treatment of patients comorbid for addiction and other psychiatric disorders (Q36960178) (← links)
- Use of risperidone long-acting injectable in a rural border community clinic in southern california (Q37225867) (← links)
- Pharmacological treatment of schizophrenia and co-occurring substance use disorders (Q37288802) (← links)
- Management of patients presenting with acute psychotic episodes of schizophrenia. (Q37423313) (← links)
- Antipsychotic treatment of adolescent dual diagnosis patients (Q38024348) (← links)
- An epidemiologic and clinical overview of medical and psychopathological comorbidities in major psychoses (Q48908840) (← links)
- Development of MLR and SVM Aided QSAR Models to Identify Common SAR of GABA Uptake Herbal Inhibitors used in the Treatment of Schizophrenia. (Q48912516) (← links)
- Dopamine D1 Receptor (D1R) Expression Is Controlled by a Transcriptional Repressor Complex Containing DISC1 (Q92642814) (← links)